Vanda Pharmaceuticals
VNDA
#8785
Rank
C$0.30 B
Marketcap
C$5.07
Share price
-3.54%
Change (1 day)
-29.75%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -C$0.25 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are C$0.22 Billion. In 2025 the company made an earning of -C$0.22 Billion a decrease over its 2024 earnings that were of -C$58.25 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.25 Billion15.09%
2025 -C$0.22 Billion271.79%
2024 -C$58.25 Million191.43%
2023 -C$19.99 Million-320.45%
2022 C$9.06 M-84.99%
2021 C$60.39 M54.8%
2020 C$39.01 M19.42%
2019 C$32.67 M4.93%
2018 C$31.13 M-228.6%
2017 -C$24.22 Million-8.98%
2016 -C$26.61 Million-53.79%
2015 -C$57.57 Million-30.18%
2014 -C$82.45 Million173.08%
2013 -C$30.19 Million-25.33%
2012 -C$40.43 Million163.61%
2011 -C$15.34 Million-221.15%
2010 C$12.65 M-124.53%
2009 -C$51.62 Million-29.44%
2008 -C$73.15 Million-36.2%
2007 -C$0.12 Billion21.81%
2006 -C$94.13 Million170.55%
2005 -C$34.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.81 B-10,622.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$18.10 B-7,206.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$9.98 B-4,016.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.80 B-19,643.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.63 B-3,878.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.23 B-6,469.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-C$4.02 Million-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA